These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31512110)

  • 21. Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study.
    Litwin AH; Jost J; Wagner K; Heo M; Karasz A; Feinberg J; Kim AY; Lum PJ; Mehta SH; Taylor LE; Tsui JI; Pericot-Valverde I; Page K;
    Contemp Clin Trials; 2019 Dec; 87():105859. PubMed ID: 31669450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Access to outpatient services in rural communities changes after hospital closure.
    Miller KEM; Miller KL; Knocke K; Pink GH; Holmes GM; Kaufman BG
    Health Serv Res; 2021 Oct; 56(5):788-801. PubMed ID: 34173227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved Hepatitis C Cure Cascade Outcomes Among Urban Baby Boomers in the Direct-Acting Antiviral Era.
    Dupont SC; Fluker SA; Quairoli KM; Body C; Okosun I; Lom J; Miller LS
    Public Health Rep; 2020 Jan; 135(1):107-113. PubMed ID: 31756116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population.
    DeBose-Scarlett A; Balise R; Kwon D; Vadaparampil S; Chen SX; Schiff ER; Ayala GP; Thomas E
    J Transl Med; 2018 Jun; 16(1):178. PubMed ID: 29954391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response.
    Lubega S; Agbim U; Surjadi M; Mahoney M; Khalili M
    Liver Int; 2013 Aug; 33(7):999-1007. PubMed ID: 23509897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.
    Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ
    Liver Int; 2019 Dec; 39(12):2261-2272. PubMed ID: 31444846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FQHC Designation and Safety Net Patient Revenue Associated with Primary Care Practice Capabilities for Access and Quality.
    Lewis VA; Spivack S; Murray GF; Rodriguez HP
    J Gen Intern Med; 2021 Oct; 36(10):2922-2928. PubMed ID: 34346005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Hepatitis C Virus Care Continuum: Linkage to Hepatitis C Virus Care and Treatment Among Patients at an Urban Health Network, Philadelphia, PA.
    Coyle C; Moorman AC; Bartholomew T; Klein G; Kwakwa H; Mehta SH; Holtzman D
    Hepatology; 2019 Aug; 70(2):476-486. PubMed ID: 30633811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system.
    Belperio PS; Backus LI; Ross D; Neuhauser MM; Mole LA
    J Manag Care Spec Pharm; 2014 Jun; 20(6):533-40. PubMed ID: 24856591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving Access to Hepatitis C Treatment Using Clinical Pharmacist Services in an Uninsured, At-Risk Population at a Community Health Center.
    Fitzgerald LS; Johnston BE; Patel B; Stillwell T
    J Health Care Poor Underserved; 2021; 32(3):1433-1443. PubMed ID: 34421041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antecedents of geographical expansion: The case of federally qualified health centers.
    Choi S; Weech-Maldonado R; Powers TL; Hearld LR
    Health Care Manage Rev; 2022 Apr-Jun 01; 47(2):E32-E40. PubMed ID: 35019863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ECHO model proved to be a useful tool to increase clinicians' self-effectiveness for care of patients with Hepatitis C in Argentina.
    Mendizabal M; Ridruejo E; Ceballos S; Sixto M; Billordo A; Gadea C; Mengarelli S; Alonso C; Palazzo A; De María L; Bruno A; Perez D; Piñero F; Deltrozzo V; Mendoza C; Figueroa S; Manero E; Villa M; Barreyro F; Moreno V; Vilar J; Murga D; Fernandez M; O Flaherty M; Arora S; Silva M;
    J Viral Hepat; 2019 Nov; 26(11):1284-1292. PubMed ID: 31273860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population.
    Stewart RA; MacDonald BR; Chu TC; Moore JD; Fasanmi EO; Ojha RP
    Dig Dis Sci; 2018 Dec; 63(12):3233-3240. PubMed ID: 30014226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achievement of hepatitis C cascade of care milestones: a population-level analysis in Alberta, Canada.
    O'Neil CR; Buss E; Plitt S; Osman M; Coffin CS; Charlton CL; Shafran S
    Can J Public Health; 2019 Dec; 110(6):714-721. PubMed ID: 31222618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Needs Assessment of HCV-Infected Individuals Experiencing Homelessness and Implications.
    Beiser M; Leon C; Gaeta JM
    J Health Care Poor Underserved; 2017; 28(1):596-606. PubMed ID: 28239021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Access to Federally Qualified Health Centers and Emergency Department Use Among Uninsured and Medicaid-insured Adults: California, 2005 to 2013.
    Nath JB; Costigan S; Lin F; Vittinghoff E; Hsia RY
    Acad Emerg Med; 2019 Feb; 26(2):129-139. PubMed ID: 30648780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of Hepatitis C Treatment in a Primary care Federally Qualified Health Center; Philadelphia, Pennsylvania, 2015-2017.
    Bartholomew TS; Grosgebauer K; Huynh K; Cos T
    Infect Dis (Auckl); 2019; 12():1178633719841381. PubMed ID: 31065216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linkage to specialty care in the hepatitis C care cascade.
    Blanding DP; Moran WP; Bian J; Zhang J; Marsden J; Mauldin PD; Rockey DC; Schreiner AD
    J Investig Med; 2021 Feb; 69(2):324-332. PubMed ID: 33203787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes.
    Mazhnaya A; Meteliuk A; Barnard T; Zelenev A; Filippovych S; Altice FL
    Int J Drug Policy; 2017 Sep; 47():187-195. PubMed ID: 28811159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of the Violence and Stress Assessment (ViStA) study: a randomized controlled trial of care management for PTSD among predominantly Latino patients in safety net health centers.
    Meredith LS; Eisenman DP; Green BL; Kaltman S; Wong EC; Han B; Cassells A; Tobin JN
    Contemp Clin Trials; 2014 Jul; 38(2):163-72. PubMed ID: 24747932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.